Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Revenue Share 8.3.4
Acta Neurol.Taiwan
While glucose is the preferred substrate for energy production in retinal neurons, under certain circumstances, including cell degeneration and glucose-deprived conditions, they use alternate fuel substrates in order to improve metabolic efficiency 9,10,11
Stay connected with the LIWLI community for the expert guidance, support, and motivation you need to keep moving forward
The most extensively studied compounds are exenatide (Byetta [Amylin Pharmaceuticals, San Diego, CA], which has been approved by the US Food and Drug Administration [FDA] for the treatment of type 2 diabetes), liraglutide (Victoza [Novo Nordisk, Princeton, NJ], which has been submitted to the FDA for approval), sitaglitptin (Januvia [Abbott Laboratories, Abbott Park, IL], which has been approved by the FDA for type 2 diabetes), and vildagliptin (Galvus [Novo Nordisk, Princeton, NJ], which has been submitted to FDA)
